Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Facchinetti, F.
Right arrow Articles by Volpe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Facchinetti, F.
Right arrow Articles by Volpe, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 10, 2224-2227, October 2000
© 2000 European Society of Human Reproduction and Embryology

Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomized controlled trial

Fabio Facchinetti1, Federica Piccinini and Annibale Volpe

Department of Gynaecologica, Obstetrics and Paediatric Sciences, University of Modena and Reggio Emilia, Modena, Italy

Nitric oxide (NO) has been found to be involved in the processes of cervical ripening. In a randomized, placebo-controlled study, cervical softening by an intracervical application of sodium nitroprusside, one of the most clinically potent and effective NO donor agents, was evaluated. A total of 36 primigravid women undergoing pregnancy termination between 9 and 12.5 weeks were enrolled. In one series, 18 patients were randomized to receive intracervically either placebo or 1% nitroprusside gel (5 mg), followed by uterine evacuation 6 h after treatment. In another series, 18 patients received either placebo or 2% nitroprusside gel (10 mg) into the cervical canal followed by uterine evacuation 3 h later. The cervical resistance, i.e. the force required to dilate the cervix from 3 to 10 mm, was the main outcome variable. It was recorded using a force sensing apparatus (dynamometer). Blood pressure was measured. Adverse events were recorded until 2 h after surgery. Women treated with both doses of nitroprusside gel showed values of cervical resistance significantly lower than those treated with placebo gel, at any tested diameter. No differences were found between subjects treated with the two different doses of nitroprusside. No significant consistent changes in blood pressure were induced by either dose of nitroprusside. No headaches were found in subjects treated with the NO donor. This study demonstrates that sodium nitroprusside applied into the cervical canal induces a rapid and significant softening of the cervix, thus reducing the force required to dilate it, compared with placebo-treated subjects. The chemical ripening of the cervix with sodium nitroprusside intracervical gel is an efficacious procedure in first-trimester pregnancy.

Key words: cervical dilation/nitric oxide/pregnancy/sodium nitroprusside

1 To whom correspondence should be addressed at: Clinica Ostetrica Ginecologica, Via del Pozzo 71, 41100 Modena, Italy. E-mail: Facchi{at}unimo.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
I. Blasi, B. Richardson, A. Volpe, and F. Facchinetti
Feto-Maternal Safety of Intracervical Sodium Nitroprusside Application in Sheep
Reproductive Sciences, September 1, 2008; 15(7): 690 - 695.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
G. Chiossi, G. Verocchi, P. Venturini, and F. Facchinetti
Changes in Cervical Nitric Oxide Concentration Correlate With Bishop Score and Cervical Length Modifications in Prostaglandin E2-Mediated Induction of Labor
Reproductive Sciences, April 1, 2006; 13(3): 203 - 208.
[Abstract] [PDF]


Home page
Hum ReprodHome page
C.C.W. Chan, O.S. Tang, E.H.Y. Ng, C.F. Li, and P.C. Ho
Intracervical sodium nitroprusside versus vaginal misoprostol in first trimester surgical termination of pregnancy: a randomized double-blinded controlled trial
Hum. Reprod., March 1, 2005; 20(3): 829 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Vaisanen-Tommiska, T. S. Mikkola, and O. Ylikorkala
Increased Release of Cervical Nitric Oxide in Spontaneous Abortion before Clinical Symptoms: A Possible Mechanism for Preabortal Cervical Ripening
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5622 - 5626.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Ben-Chetrit, T. Eldar-Geva, T. Lindenberg, M. Farhat, S. Shimonovitz, D. Zacut, H. Gelber, R. Sitruk-Ware, and I. M. Spitz
Mifepristone does not induce cervical softening in non-pregnant women
Hum. Reprod., October 1, 2004; 19(10): 2372 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. Piccinini, R. A. Fano, A. Volpe, and F. Facchinetti
Ripening of the Cervix With Sodium Nitroprusside in Nonpregnant Women
Reproductive Sciences, October 1, 2003; 10(7): 438 - 442.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.